Abstract
In 2007, approximately 33 million people were estimated to be living with human immunodeficiency virus (HIV)-1 worldwide. An estimated 2.5 million became newly infected with HIV-1 that year, while an estimated 2.1 million died of AIDS. This means that everyday almost 6,850 people are newly infected with HIV-1, and over 5,750 die from AIDS, mostly because of inadequate access to HIV-1 prevention and treatment services. In the 27 years since the first cases of AIDS were described, approximately 20 million people have died from AIDS.
CB and KL contributed equally to this chapter
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Notes
- 1.
* CB and KL contributed equally to this chapter
References
AIDSinfo (2008) HIV-1 LifeCycle. http://www.aidsinfo.nih.gov/contentfiles/HIVLifeCycle_FS_en.pdf
Almeda J, Casabona J, Simon B, Gerard M, Rey D, Puro V et al. (2004) Proposed recommendations for the management of HIV post-exposure prophylaxis after sexual, injecting drug or other exposures in Europe. Euro Surveillance : Bulletin Europeen sur les Maladies Transmissibles = European Communicable Disease Bulletin; 9(6):35–40
Alter MJ (2006) Epidemiology of viral hepatitis and HIV co-infection. J Hepatol; 44(1 Suppl):S6–S9
Auvert B, Taljaard D, Lagarde E, Sobngwi-Tambekou J, Sitta R, Puren A (2005) Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial. PLoS Medicine/Public Library of Science; 2(11):e298
Bailey RC, Moses S, Parker CB, Agot K, Maclean I, Krieger JN et al. (2007) Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet; 369(9562):643–656
Chan DJ (2006) Fatal attraction: sex, sexually transmitted infections and HIV-1. Int J STD AIDS; 17(10):643–651
Coakley E, Petropoulos CJ, Whitcomb JM (2005) Assessing chemokine co-receptor usage in HIV. Curr Opin Infect Dis; 18(1):9–15
Collaborative Group on AIDS incubation and HIV survival including the CASCADE EU Concerted Action(2000) Time from HIV-1 seroconversion to AIDS and death before widespread use of highly-active antiretroviral therapy: a collaborative re-analysis. Lancet; 355:1131–1137
Cooper ER, Charurat M, Mofenson L, Hanson IC, Pitt J, Diaz C et al. (2002) Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission. J Acquir Immune Defic Syndr; 29(5):484–494
Corey L, Wald A, Celum CL, Quinn TC (2004) The effects of herpes simplex virus-2 on HIV-1 acquisition and transmission: a review of two overlapping epidemics. J Acquir Immune Defic Syndr; 35(5):435–445
Corbett EL, Marston B, Churchyard GJ, De Cock KM (2006) Tuberculosis in sub-Saharan Africa: opportunities, challenges, and change in the era of antiretroviral treatment. Lancet; 367(9514):926–937
Corbett EL, Watt CJ, Walker N, Maher D, Williams BG, Raviglione MC et al. (2003) The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med; 163(9):1009–1021
Dao H, Mofenson LM, Ekpini R, Gilks CF, Barnhart M, Bolu O et al. (2007) International recommendations on antiretroviral drugs for treatment of HIV-infected women and prevention of mother-to-child HIV transmission in resource-limited settings: 2006 update. Am J Obstet Gynecol; 197(3 Suppl):S42–S55
Ellerbrock TV, Bush TJ, Chamberland ME, Oxtoby MJ (1991) Epidemiology of women with AIDS in the United States. 1981 through 1990 A comparison with heterosexual men with AIDS. JAMA; 265(22):2971–2975
el-Sadr WM, Lundgren JD, Neaton JD, Gordin F, AbramsD, Arduino RC et al. (2006) CD4+ count-guided interruption of antiretroviral treatment. N Engl J Med; 355(22):2283–2296
Eshleman SH, Mracna M, Guay LA, Deseyve M, Cunningham S, Mirochnick M et al. (2001) Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET 012). AIDS; 15(15):1951–1957
EuroHIV (2007) HIV/AIDS Surveillance in Europe. End-year report 2006.Saint-Maurice: Institut de veille sanitaire
Fowler MG, Lampe MA, Jamieson DJ, Kourtis AP, Rogers MF (2007) Reducing the risk of mother-to-child human immunodeficiency virus transmission: past successes, current progress and challenges, and future directions. Am J Obstet Gynecol; 197(3 Suppl):S3–S9
Fowler MG, Newell ML (2002) Breast-feeding and HIV-1 transmission in resource-limited settings. J Acquir Immune Defic Syndr; 30(2):230–239
French MA (2007) Disorders of immune reconstitution in patients with HIV infection responding to antiretroviral therapy. Curr HIV/AIDS Rep; 4(1):16–21
Gilks CF, Crowley S, Ekpini R, Gove S, Perriens J, Souteyrand Y et al. (2006) The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings. Lancet; 368(9534):505–510
Gray RH, Kigozi G, Serwadda D, Makumbi F, Watya S, Nalugoda F et al. (2007) Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet; 369(9562):657–666
Guay LA, Musoke P, Fleming T, Bagenda D, Allen M, Nakabiito C et al. (1999) Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet; 354(9181):795–802
Geretti AM (2006) HIV-1 subtypes: epidemiology and significance for HIV management. Curr Opin Infect Dis; 19(1):1–7
Jamieson DJ, Read JS, Kourtis AP, Durant TM, Lampe MA, Dominguez KL (2007) Cesarean delivery for HIV-infected women: recommendations and controversies. Am J Obstet Gynecol; 197(3 Suppl):S96–S100
Kanki PJ, Peeters M, Gueye-Ndiaye A (1997) Virology of HIV-1 and HIV-2: implications for Africa. AIDS; 11 Suppl B:S33–S42
Koziel MJ, Peters MG (2007) Viral hepatitis in HIV infection. N Engl J Med 2007; 356(14):1445–1454
Liu Z, Lian Z, Zhao C (2006) Drug use and HIV/AIDS in China. Drug Alcohol Rev; 25(2):173–175
Luzuriaga K, Sullivan JL (2005) Prevention of mother-to-child transmission of HIV infection. Clin Infect Dis; 40(3):466–467
Montessori V, Press N, Harris M, Akagi L, Montaner JS (2004) Adverse effects of antiretroviral therapy for HIV infection. Can Med Assoc J; 170(2):229–238
Myers G, MacInnes K, Korber B (1992) The emergence of simian/human immunodeficiency viruses. AIDS Res Hum Retroviruses; 8(3):373–386
Paterson DL, Swindells S, Mohr J, Brester M, Vergis EN, Squier C et al. (2000) Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med; 133(1):21–30
Pezzotti P, Phillips AN, Dorrucci M, Lepri AC, Galai N, Vlahov D et al. (1996) Category of exposure to HIV and age in the progression to AIDS: longitudinal study of 1199 people with known dates of seroconversion. HIV Italian Seroconversion Study Group. BMJ; 313(7057):583–586
Pinkerton SD, Holtgrave DR, Pinkerton HJ (1997) Cost-effectiveness of chemoprophylaxis after occupational exposure to HIV. Arch Intern Med; 157(17):1972–1980
Peeters M (2000) Recombinant HIV-1 Sequences: their role in global epidemic. In: Kuiken C FBHBE, editor. HIV-1 Sequence Compendium. Theoretical Biology and Biophysics Group, Los Alamos National Laboratory: Los Alamos: 39–54
Schacker T, Zeh J, Hu HL, Hill E, Corey L (1998) Frequency of symptomatic and asymptomatic herpes simplex virus type 2 reactivations among human immunodeficiency virus-infected men. J Infect Dis; 178(6):1616–1622
Shepard CW, Finelli L, Alter MJ (2005) Global epidemiology of hepatitis C virus infection. Lancet Infect Dis; 5(9):558–567
Stebbing J, Moyle G (2003) The clades of HIV: their origins and clinical significance. AIDS Rev; 5(4):205–213
Stover J, Bertozzi S, Gutierrez JP, Walker N, Stanecki KA, Greener R et al. (2006) The global impact of scaling up HIV/AIDS prevention programs in low- and middle-income countries. Science; 311(5766):1474–1476
UNAIDS (2008) AIDS epidemic update : December 2007
Wald A, Link K (2002) Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: a meta-analysis. J Infect Dis; 185(1):45–52
Wawer MJ, Gray RH, Sewankambo NK, Serwadda D, Li X, Laeyendecker O et al. (2005) Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda. J Infect Dis; 191(9):1403–1409
Weller IV, Williams IG (2001) ABC of AIDS. Antiretroviral drugs. BMJ; 322(7299):1410–1412
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
van den Berg, C., Lindenburg, K., Coutinho, R. (2009). Bloodborne and Sexual Transmission: HIV/AIDS. In: Krämer, A., Kretzschmar, M., Krickeberg, K. (eds) Modern Infectious Disease Epidemiology. Statistics for Biology and Health. Springer, New York, NY. https://doi.org/10.1007/978-0-387-93835-6_18
Download citation
DOI: https://doi.org/10.1007/978-0-387-93835-6_18
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-93834-9
Online ISBN: 978-0-387-93835-6
eBook Packages: Mathematics and StatisticsMathematics and Statistics (R0)